R E Heikkila - JoVE Visualize

Showing results (71-80 of 87) with videos related to

Pageof 9

Sort By:

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1981

Unexpected differences between mazindol and its homologs on biochemical and behavioral responsesR E Heikkila, F S Cabbat, L Manzino, et al.

Journal of Neurochemistry|January 1, 1985

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparationsR E Heikkila, S K Youngster, L Manzino, et al.

Journal of Neurochemistry|September 1, 1990

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase AA N Basma, R E Heikkila, W J Nicklas, et al.

Toxicology|May 1, 1988

Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogsR E Heikkila, S K Youngster, D U Panek, et al.

Prostaglandins|April 1, 1976

Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesisR V Panganamala, H M Sharma, R E Heikkila, et al.

European Neurology|January 1, 1990

Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'D M McHale, J I Sage, P K Sonsalla, et al.

European Journal of Pharmacology|February 9, 1988

Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTPM V Kindt, S K Youngster, P K Sonsalla, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992

Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respirationM S Saporito, R E Heikkila, S K Youngster, et al.

Journal of Neurochemistry|March 1, 1992

1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysisA N Basma, R E Heikkila, M S Saporito, et al.

European Journal of Pharmacology|March 18, 1986

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceS K Youngster, R C Duvoisin, A Hess, et al.

Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:

Pageof 9

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1981

Unexpected differences between mazindol and its homologs on biochemical and behavioral responsesR E Heikkila, F S Cabbat, L Manzino, et al.

Journal of Neurochemistry|January 1, 1985

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparationsR E Heikkila, S K Youngster, L Manzino, et al.

Journal of Neurochemistry|September 1, 1990

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase AA N Basma, R E Heikkila, W J Nicklas, et al.

Toxicology|May 1, 1988

Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogsR E Heikkila, S K Youngster, D U Panek, et al.

Prostaglandins|April 1, 1976

Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesisR V Panganamala, H M Sharma, R E Heikkila, et al.

European Neurology|January 1, 1990

Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'D M McHale, J I Sage, P K Sonsalla, et al.

European Journal of Pharmacology|February 9, 1988

Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTPM V Kindt, S K Youngster, P K Sonsalla, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992

Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respirationM S Saporito, R E Heikkila, S K Youngster, et al.

Journal of Neurochemistry|March 1, 1992

1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysisA N Basma, R E Heikkila, M S Saporito, et al.

European Journal of Pharmacology|March 18, 1986

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceS K Youngster, R C Duvoisin, A Hess, et al.

Pageof 9